The global multiplex molecular diagnostics market is expected to reach US$ 23.2 Billion in 2022, and to US$ 39.25 Billion by 2032, growing at a CAGR of 5.4% from 2022 to 2032. The market growth is attributed to factors such as increasing prevalence of infectious diseases, rising demand for personalized medicine, and technological advancements in …